Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Capital Reinvestment Ratio
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Capital Reinvestment Ratio of 0.52x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥1.25 Billion) in capital expenditures (CN¥652.49 Million). See 600866 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Starlake Bioscience Co Inc Zhaoqing Guangdong Capital Reinvestment Ratio (1998–2025)
This chart tracks Starlake Bioscience Co Inc Zhaoqing Guangdong's Capital Reinvestment Ratio across 25 annual periods. Check cash flow reinvestment rate of Starlake Bioscience Co Inc Zhaoqing Guan to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year Capital Reinvestment Ratio for Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. For live market cap and broader valuation context, see Starlake Bioscience Co Inc Zhaoqing Guan stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.58x | CN¥1.29 Billion | CN¥2.04 Billion | ▲ +492.5% |
| 2024 | 0.27x | CN¥2.40 Billion | CN¥638.50 Million | ▲ +43.6% |
| 2023 | 0.19x | CN¥2.03 Billion | CN¥375.83 Million | ▼ -31.8% |
| 2022 | 0.27x | CN¥1.66 Billion | CN¥452.34 Million | ▼ -74.4% |
| 2021 | 1.06x | CN¥192.63 Million | CN¥205.08 Million | ▼ -8.2% |
| 2020 | 1.16x | CN¥249.99 Million | CN¥289.89 Million | ▲ +57.0% |
| 2019 | 0.74x | CN¥213.17 Million | CN¥157.41 Million | ▲ +11.0% |
| 2018 | 0.67x | CN¥50.69 Million | CN¥33.71 Million | ▼ -34.4% |
| 2017 | 1.01x | CN¥40.05 Million | CN¥40.61 Million | ▲ +3.7% |
| 2016 | 0.98x | CN¥41.17 Million | CN¥40.26 Million | ▼ -97.4% |
| 2015 | 37.70x | CN¥2.75 Million | CN¥103.49 Million | ▲ +189.0% |
| 2011 | 13.05x | CN¥65.88 Million | CN¥859.52 Million | ▲ +244.3% |
| 2010 | 3.79x | CN¥104.63 Million | CN¥396.40 Million | ▲ +1816.9% |
| 2009 | 0.20x | CN¥316.73 Million | CN¥62.60 Million | ▼ -41.1% |
| 2008 | 0.34x | CN¥148.93 Million | CN¥49.97 Million | ▼ -63.1% |
| 2007 | 0.91x | CN¥82.28 Million | CN¥74.90 Million | ▼ -58.6% |
| 2006 | 2.20x | CN¥35.14 Million | CN¥77.37 Million | ▲ +47.8% |
| 2005 | 1.49x | CN¥46.83 Million | CN¥69.77 Million | ▼ -80.4% |
| 2004 | 7.60x | CN¥29.05 Million | CN¥220.76 Million | ▲ +932.9% |
| 2003 | 0.74x | CN¥149.70 Million | CN¥110.12 Million | ▲ +52.8% |
| 2002 | 0.48x | CN¥183.18 Million | CN¥88.18 Million | ▼ -62.1% |
| 2001 | 1.27x | CN¥60.82 Million | CN¥77.35 Million | ▲ +76.9% |
| 2000 | 0.72x | CN¥93.41 Million | CN¥67.16 Million | ▼ -52.1% |
| 1999 | 1.50x | CN¥52.97 Million | CN¥79.45 Million | ▼ -6.2% |
| 1998 | 1.60x | CN¥71.14 Million | CN¥113.73 Million | — |